Preparation and interaction of a low-density lipoprotein:daunomycin complex with P388 leukemic cells
- PMID: 6692404
Preparation and interaction of a low-density lipoprotein:daunomycin complex with P388 leukemic cells
Abstract
A low-density lipoprotein (LDL):daunomycin complex was prepared which contains, on the average, 8 nmol of daunomycin/mg of apolipoprotein. LDL was not perturbed to any significant degree by association with daunomycin, and the complex remained stable at 4 degrees. Fluorescence quenching with DNA and potassium iodide, antibody precipitation, and density flotation studies suggested at least two domains for localization of the daunomycin, the surface region and the hydrophobic core of the LDL particle. Interaction of the LDL:daunomycin complex with P388 leukemic cells which were sensitive or resistant to daunomycin occurred rapidly in both sublines, with quantitatively larger amounts of the drug being cell associated than when free drug was used alone. The cells appeared morphologically intact, with no nuclear damage after short-term incubation with LDL:daunomycin. Subfractionation of cell membranes and organelles from the sensitive and resistant cell lines incubated with LDL:daunomycin showed accumulation of drug in the plasma membrane and microsomal-lysosomal-mitochondrial membranes and an insoluble nuclear chromatin material. Both 125l-labeled apoprotein and daunomycin from a 125l-LDL:daunomycin complex showed enrichment in similar membrane:organelle fractions of the P388 cells.
Similar articles
-
Characteristics of uptake and cytotoxicity of a low-density lipoprotein-daunomycin complex in P388 leukemic cells.Cancer Res. 1984 Aug;44(8):3377-82. Cancer Res. 1984. PMID: 6744272
-
Differences in daunomycin retention in sensitive and resistant P388 leukemic cells as determined by digitized video fluorescence microscopy.Cancer Res. 1983 Sep;43(9):4167-71. Cancer Res. 1983. PMID: 6871858
-
Effects of verapamil on daunomycin cellular retention and cytotoxicity in P388 leukemic cells.Cancer Res. 1984 May;44(5):1743-7. Cancer Res. 1984. PMID: 6713377
-
Exploring multidrug resistance using rhodamine 123.Cancer Commun. 1989;1(3):145-9. Cancer Commun. 1989. PMID: 2639727
-
Different distribution of daunomycin in plasma membranes from drug-sensitive and drug-resistant P388 leukemia cells.Biochim Biophys Acta. 1992 Feb 17;1104(1):111-6. doi: 10.1016/0005-2736(92)90138-c. Biochim Biophys Acta. 1992. PMID: 1550837
Cited by
-
Effect of neoadjuvant chemotherapy on low-density lipoprotein (LDL) receptor and LDL receptor-related protein 1 (LRP-1) receptor in locally advanced breast cancer.Braz J Med Biol Res. 2012 Jun;45(6):557-64. doi: 10.1590/s0100-879x2012007500068. Epub 2012 May 10. Braz J Med Biol Res. 2012. PMID: 22570085 Free PMC article.
-
Enhanced blood-brain barrier penetration and glioma therapy mediated by T7 peptide-modified low-density lipoprotein particles.Drug Deliv. 2018 Nov;25(1):1652-1663. doi: 10.1080/10717544.2018.1494223. Drug Deliv. 2018. PMID: 30394123 Free PMC article.
-
Low density lipoprotein for cytotoxic drug targeting: improved activity of elliptinium derivative against B16 melanoma in mice.Br J Cancer. 1993 Aug;68(2):319-26. doi: 10.1038/bjc.1993.335. Br J Cancer. 1993. PMID: 8347487 Free PMC article.
-
Low density lipoprotein for delivery of a water-insoluble alkylating agent to malignant cells. In vitro and in vivo studies of a drug-lipoprotein complex.Br J Cancer. 1990 Nov;62(5):724-9. doi: 10.1038/bjc.1990.367. Br J Cancer. 1990. PMID: 2245164 Free PMC article.
-
The distribution of porphyrins with different tumour localising ability among human plasma proteins.Br J Cancer. 1989 Feb;59(2):184-8. doi: 10.1038/bjc.1989.38. Br J Cancer. 1989. PMID: 2930683 Free PMC article.